BIM
Bridgecreek Investment Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-144,610
| Closed | -$18.7M | – | 121 |
|
|
2021
Q4 | $18.7M | Sell |
144,610
-75
| -0.1% | -$9.72K | 2.56% | 12 |
|
|
2021
Q3 | $16.4M | Sell |
144,685
-605
| -0.4% | -$68.5K | 2.34% | 13 |
|
|
2021
Q2 | $15M | Sell |
145,290
-13,965
| -9% | -$1.45M | 2.19% | 15 |
|
|
2021
Q1 | $13.3M | Sell |
159,255
-1,410
| -0.9% | -$118K | 2.06% | 15 |
|
|
2020
Q4 | $14.7M | Buy |
160,665
+1,350
| +0.8% | +$123K | 2.22% | 16 |
|
|
2020
Q3 | $12.7M | Buy |
159,315
+120
| +0.1% | +$9.58K | 2.23% | 15 |
|
|
2020
Q2 | $11M | Buy |
159,195
+106,170
| +200% | +$7.34M | 2.06% | 15 |
|
|
2020
Q1 | $10M | Buy |
53,025
+1,325
| +3% | +$250K | 2.59% | 13 |
|
|
2019
Q4 | $12.1M | Buy |
51,700
+75
| +0.1% | +$17.5K | 2.19% | 12 |
|
|
2019
Q3 | $11.4M | Buy |
51,625
+380
| +0.7% | +$83.6K | 2.36% | 10 |
|
|
2019
Q2 | $9.47M | Buy |
51,245
+155
| +0.3% | +$28.6K | 1.98% | 15 |
|
|
2019
Q1 | $9.78M | Buy |
51,090
+885
| +2% | +$169K | 2.07% | 13 |
|
|
2018
Q4 | $7.69M | Sell |
50,205
-495
| -1% | -$75.8K | 2.05% | 14 |
|
|
2018
Q3 | $8.83M | Buy |
50,700
+210
| +0.4% | +$36.6K | 1.76% | 16 |
|
|
2018
Q2 | $7.35M | Buy |
50,490
+500
| +1% | +$72.8K | 1.6% | 22 |
|
|
2018
Q1 | $6.98M | Buy |
49,990
+1,025
| +2% | +$143K | 1.57% | 22 |
|
|
2017
Q4 | $5.52M | Buy |
48,965
+3,995
| +9% | +$450K | 1.3% | 31 |
|
|
2017
Q3 | $4.92M | Buy |
44,970
+2,675
| +6% | +$292K | 1.34% | 33 |
|
|
2017
Q2 | $5M | Buy |
42,295
+5,750
| +16% | +$680K | 1.34% | 36 |
|
|
2017
Q1 | $3.44M | Buy |
36,545
+10,700
| +41% | +$1.01M | 0.93% | 50 |
|
|
2016
Q4 | $2.42M | Buy |
+25,845
| New | +$2.42M | 0.68% | 57 |
|